Literature DB >> 1759813

Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.

D E Nix1, S D Goodwin, C A Peloquin, D L Rotella, J J Schentag.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1759813      PMCID： PMC245307          DOI： 10.1128/AAC.35.10.1953

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  97 in total

Review 1.  The use of antibiotic serum levels to predict concentrations in tissues.

Authors:  D M Ryan; O Cars; B Hoffstedt
Journal:  Scand J Infect Dis       Date:  1986

Review 2.  The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy.

Authors:  R Wise
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

3.  Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity.

Authors:  W L Hand; N L King-Thompson
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

4.  Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats.

Authors:  R Roosendaal; I A Bakker-Woudenberg; M van den Berghe-van Raffe; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

5.  Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections.

Authors:  D E Nix; M F Sands; C A Peloquin; A J Vari; T J Cumbo; J W Vance; J E Fracasso; J J Schentag
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

6.  Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.

Authors:  R D Moore; P S Lietman; C R Smith
Journal:  J Infect Dis       Date:  1987-01       Impact factor: 5.226

7.  Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies.

Authors:  C S Easmon; J P Crane; A Blowers
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

8.  Potential impact of quantitative susceptibility tests on the design of aminoglycoside dosing regimens.

Authors:  J P McCormack; J J Schentag
Journal:  Drug Intell Clin Pharm       Date:  1987-02

9.  Vancomycin enhancement of experimental tobramycin nephrotoxicity.

Authors:  C A Wood; S J Kohlhepp; P W Kohnen; D C Houghton; D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

10.  In vivo postantibiotic effect in a thigh infection in neutropenic mice.

Authors:  B Vogelman; S Gudmundsson; J Turnidge; J Leggett; W A Craig
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226
View more
  40 in total

Review 1.  Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials.

Authors:  R C Li; M Zhu; J J Schentag
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

Review 2.  Comparative pharmacokinetics of the carbapenems: clinical implications.

Authors:  J W Mouton; D J Touzw; A M Horrevorts; A A Vinks
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

Review 3.  Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases.

Authors:  P S McKinnon; S L Davis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-10       Impact factor: 3.267

Review 4.  Lung microdialysis--a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review).

Authors:  Markus Zeitlinger; Markus Müller; Christian Joukhadar
Journal:  AAPS J       Date:  2005-10-22       Impact factor: 4.009

Review 5.  Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

6.  Comparison of the pharmacodynamics of biapenem in bronchial epithelial lining fluid in healthy volunteers given half-hour and three-hour intravenous infusions.

Authors:  Eiki Kikuchi; Junko Kikuchi; Yasuyuki Nasuhara; Satoshi Oizumi; Akitoshi Ishizaka; Masaharu Nishimura
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

Review 7.  Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

Authors:  Andrew A Udy; Jason A Roberts; Jeffrey Lipman
Journal:  Intensive Care Med       Date:  2013-09-18       Impact factor: 17.440

8.  Telavancin penetration into human epithelial lining fluid determined by population pharmacokinetic modeling and Monte Carlo simulation.

Authors:  Thomas P Lodise; Mark Gotfried; Steven Barriere; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2008-04-21       Impact factor: 5.191

Review 9.  Interpretation of antibiotic concentration ratios measured in epithelial lining fluid.

Authors:  Sungmin Kiem; Jerome J Schentag
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

10.  Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions.

Authors:  Alvaro A Ordonez; Hechuan Wang; Gesham Magombedze; Camilo A Ruiz-Bedoya; Shashikant Srivastava; Allen Chen; Elizabeth W Tucker; Michael E Urbanowski; Lisa Pieterse; E Fabian Cardozo; Martin A Lodge; Maunank R Shah; Daniel P Holt; William B Mathews; Robert F Dannals; Jogarao V S Gobburu; Charles A Peloquin; Steven P Rowe; Tawanda Gumbo; Vijay D Ivaturi; Sanjay K Jain
Journal:  Nat Med       Date:  2020-02-17       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.